Addressing Gene Editing & Modifications to Enable More Complex Cell Therapies
Time: 3:30 pm
day: Conference Day One
Details:
- Leveraging CRISPR knock-in gene editing to increase sensitivity, potency, and safety of transgenic TCR-expressing T-cell therapies
- Harnessing armoring strategies to induce a coordinated immune response that resists exhaustion and allows for durable functional persistence of the engineered T-cells
